1. Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, Liu L, Shan H, Lei C, Hui DSC, Du B, Li L, Zeng G, Yuen K-Y, Chen R, Tang C, Wang T, Chen P, Xiang J, Li S, Wang J, Liang Z, Peng Y, Wei L, Liu Y, Hu Y, Peng P, Wang J, Liu J, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. New England Journal of Medicine 2020;382:1708–1720.
2. World Health Organization. WHO Coronavirus (COVID-19) Dashboard. at <https://covid19.who.int/>.
3. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China. JAMA 2020;323:1239.
4. Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, Cereda D, Coluccello A, Foti G, Fumagalli R, Iotti G, Latronico N, Lorini L, Merler S, Natalini G, Piatti A, Ranieri MV, Scandroglio AM, Storti E, Cecconi M, Pesenti A, Agosteo E, Alaimo V, Albano G, Albertin A, Alborghetti A, Aldegheri G, Antonini B, Barbara E, et al. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA 2020;323:1574.
5. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet 2020;395:1054–1062.
6. al Sulaiman KA, Aljuhani O, Eljaaly K, Alharbi AA, al Shabasy AM, Alsaeedi AS, al Mutairi M, Badreldin HA, al Harbi SA, al Haji HA, al Zumai OI, Vishwakarma RK, Alkatheri A. Clinical features and outcomes of critically ill patients with coronavirus disease 2019 (COVID-19): A multicenter cohort study. International Journal of Infectious Diseases 2021;105:180–187.
7. Coomes EA, Haghbayan H. Interleukin-6 in COVID-19: A systematic review and meta-analysis. medRxiv 2020;doi:10.1101/2020.03.30.20048058.
8. Yang X, Jin Y, Li R, Zhang Z, Sun R, Chen D. Prevalence and impact of acute renal impairment on COVID-19: a systematic review and meta-analysis. Critical Care 2020;24:356.
9. Ahmad I, Rathore FA. Neurological manifestations and complications of COVID-19: A literature review. Journal of Clinical Neuroscience 2020;77:8–12.
10. National Institutes of Health. NIH COVID-19 Treatment Guidelines: Pharmacologic Interventions. at <https://www.covid19treatmentguidelines.nih.gov/management/critical-care/pharmacologic-interventions/>.
11. Arabi YM, Chrousos GP, Meduri GU. The ten reasons why corticosteroid therapy reduces mortality in severe COVID-19. Intensive Care Medicine 2020;46:2067–2070.
12. Pujari R, Thommana M v, Ruiz Mercedes B, Serwat A. Therapeutic Options for COVID-19: A Review. Cureus 2020;doi:10.7759/cureus.10480.
13. RECOVERY Collaborative Group. Dexamethasone in Hospitalized Patients with Covid-19. New England Journal of Medicine 2021;384:693–704.
14. van Paassen J, Vos JS, Hoekstra EM, Neumann KMI, Boot PC, Arbous SM. Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes. Critical Care 2020;24:696.
15. Hyun JH, Kim MH, Sohn Y, Cho Y, Baek YJ, Kim JH, Ahn JY, Choi JY, Yeom JS, Ahn MY, Kim EJ, Baek J-H, Kim YK, Choi H, Jeong SJ. Effects of early corticosteroid use in patients with severe coronavirus disease 2019. BMC Infectious Diseases 2021;21:506.
16. Monedero P, Gea A, Castro P, Candela-Toha AM, Hernández-Sanz ML, Arruti E, Villar J, Ferrando C. Early corticosteroids are associated with lower mortality in critically ill patients with COVID-19: a cohort study. Critical Care 2021;25:2.
17. Fadel R, Morrison AR, Vahia A, Smith ZR, Chaudhry Z, Bhargava P, Miller J, Kenney RM, Alangaden G, Ramesh MS, Nauriyal V, Lakshmikanth J, Abdul Hamed A, Nadeem O, Griebe K, Johnson JM, Bradley P, Uduman J, Hegab S, Swiderek J, Godfrey A, Jennings J, Gardner-Gray J, Ackerman A, Lezotte J, Ruhala J, Samuel L, Tibbetts RJ, Brar I, et al. Early Short-Course Corticosteroids in Hospitalized Patients With COVID-19. Clinical Infectious Diseases 2020;71:2114–2120.
18. Timing of Corticosteroids in COVID-19. at <https://clinicaltrials.gov/ct2/show/NCT04530409>.
19. Saudi Ministry of Health. Saudi MoH Protocol for Patients Suspected of/Confirmed with COVID-19: Supportive care and antiviral treatment of suspected or confirmed COVID-19 infection (version 2.0) June 17th. 2020. at <https://covid19.cdc.gov.sa>.
20. Lin C-Y. Acute kidney injury classification: AKIN and RIFLE criteria in critical patients. World Journal of Critical Care Medicine 2012;1:40.
21. Aleidan FAS, Alkhelaifi H, Alsenaid A, Alromaizan H, Alsalham F, Almutairi A, Alsulaiman K, Abdel Gadir AG. Incidence and risk factors of carbapenem-resistant Enterobacteriaceae infection in intensive care units: a matched case–control study. Expert Review of Anti-infective Therapy 2021;19:393–398.
22. Koenig SM, Truwit JD. Ventilator-Associated Pneumonia: Diagnosis, Treatment, and Prevention. Clinical Microbiology Reviews 2006;19:637–657.
23. ICD - ICD-10-CM - International Classification of Diseases, Tenth Revision, Clinical Modification. 2021;
24. Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. The Lancet 2020;395:1033–1034.
25. Jamilloux Y, Henry T, Belot A, Viel S, Fauter M, el Jammal T, Walzer T, François B, Sève P. Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions. Autoimmunity Reviews 2020;19:102567.
26. National Isntitutes of Health. NIH Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. at <m https://www.covid19treatmentguidelines.nih.gov/>.
27. COVID-19 Clinical management: Living Guidance, 25 January 2021. at <https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-1>.
28. Alhazzani W, Møller MH, Arabi YM, Loeb M, Gong MN, Fan E, Oczkowski S, Levy MM, Derde L, Dzierba A, Du B, Aboodi M, Wunsch H, Cecconi M, Koh Y, Chertow DS, Maitland K, Alshamsi F, Belley-Cote E, Greco M, Laundy M, Morgan JS, Kesecioglu J, McGeer A, Mermel L, Mammen MJ, Alexander PE, Arrington A, Centofanti JE, et al. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Medicine 2020;46:854–887.
29. Sterne JAC, Murthy S, Diaz J v., Slutsky AS, Villar J, Angus DC, Annane D, Azevedo LCP, Berwanger O, Cavalcanti AB, Dequin P-F, Du B, Emberson J, Fisher D, Giraudeau B, Gordon AC, Granholm A, Green C, Haynes R, Heming N, Higgins JPT, Horby P, Jüni P, Landray MJ, le Gouge A, Leclerc M, Lim WS, Machado FR, McArthur C, et al. Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19. JAMA 2020;324:1330.
30. Bahl A, Johnson S, Chen N-W. Timing of corticosteroids impacts mortality in hospitalized COVID-19 patients. Internal and Emergency Medicine 2021;doi:10.1007/s11739-021-02655-6.
31 PA Harris, R Taylor, R Thielke, J Payne, N Gonzalez, JG. Conde, Research electronic data capture (REDCap) – A metadata-driven methodology and workflow process for providing translational research informatics support, J Biomed Inform. 2009 Apr;42(2):377-81.
32. PA Harris, R Taylor, BL Minor, V Elliott, M Fernandez, L O’Neal, L McLeod, G Delacqua, F Delacqua, J Kirby, SN Duda, REDCap Consortium, The REDCap consortium: Building an international community of software partners, J Biomed Inform. 2019 May 9 [doi: 10.1016/j.jbi.2019.103208]